Rational design of DXd derivatives for liposomal drug delivery: Towards safer and more effective cancer treatments

已完结 20 由 ASshen 发布于 2025/9/5 19:42:30

DOI:10.1016/j.ijpharm.2025.125688
作者：Jinbo Li ,?Jiang Yu ,?Baoyue Zhang ,?Jia Song ,?Ruiping Huang ,?Ning Li ,?Yingxi Zhang ,?Shuang Zhou ,?Xin Li ,?Zhonggui He ,?Hongzhuo Liu ,?Yongjun Wang
文献类型：期刊论文
补充材料：只需要正文

其它数据库

Abstract：DXd (Exatecan derivative), a novel TOPO-I inhibitor, exhibits high membrane permeability and an efficient bystander effect, serving as a critical cytotoxic drug component in antibody-drug co

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Meta-Analysis of Interobserver Agreement in Assessment of Interstitial Lung Disease Using High-Resolution CT.